|
SLAIN2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.55600000007317E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.5322999999976E-05 |
| Normal-vs-Stage2 |
5.259600E-03 |
| Normal-vs-Stage3 |
7.015600E-04 |
| Normal-vs-Stage4 |
4.985900E-02 |
| Stage1-vs-Stage2 |
8.966200E-01 |
| Stage1-vs-Stage3 |
3.442600E-01 |
| Stage1-vs-Stage4 |
7.695800E-01 |
| Stage2-vs-Stage3 |
5.026800E-01 |
| Stage2-vs-Stage4 |
8.287800E-01 |
| Stage3-vs-Stage4 |
7.539800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.77930000000437E-06 |
| Normal-vs-AfricanAmerican |
2.447300E-04 |
| Normal-vs-Asian |
4.00420000000734E-05 |
| Caucasian-vs-AfricanAmerican |
9.669200E-01 |
| Caucasian-vs-Asian |
2.605800E-01 |
| AfricanAmerican-vs-Asian |
1.892210E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.2480999979696E-08 |
| Normal-vs-Female |
2.490100E-02 |
| Male-vs-Female |
6.153600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.11869999999981E-05 |
| Normal-vs-Extreme_Weight |
1.54780999999105E-05 |
| Normal-vs-Obese |
6.101100E-03 |
| Normal-vs-Extreme_Obese |
4.041800E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.813200E-01 |
| Normal_Weight-vs-Obese |
1.189980E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.059400E-01 |
| Extreme_Weight-vs-Obese |
1.905960E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.950800E-01 |
| Obese-vs-Extreme_Obese |
6.668000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.196600E-03 |
| Normal-vs-Age(41-60Yrs) |
1.420950E-03 |
| Normal-vs-Age(61-80Yrs) |
3.18919999964251E-07 |
| Normal-vs-Age(81-100Yrs) |
1.682370E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.120000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.790200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.917000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.070650E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.422170E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.030400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.63220000000331E-05 |
| Normal-VS-Type2 PRCC |
1.32159999999271E-06 |
| Normal-VS-KIRP CIMP |
2.0647999999901E-05 |
| Normal-VS-Unclassified PRCC |
7.838300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.850960E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.517400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.059000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.399400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.850400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.081430E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.48840000511331E-08 |
| Normal-vs-N1 |
3.758100E-04 |
| Normal-vs-N2 |
6.007500E-04 |
| N0-vs-N1 |
9.415400E-01 |
| N0-vs-N2 |
6.917200E-01 |
| N1-vs-N2 |
7.012000E-01 |
|
|
